TY  - GEN
AU  - Moulis,Guillaume
AU  - Sommet,Agnès
AU  - Lapeyre-Mestre,Maryse
AU  - Montastruc,Jean-Louis
TI  - Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database
SN  - 1462-0332
PY  - 2015///0123
KW  - Adalimumab
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Case-Control Studies
KW  - Databases, Pharmaceutical
KW  - Etanercept
KW  - Female
KW  - Humans
KW  - Immunoglobulin G
KW  - Infliximab
KW  - Lupus Erythematosus, Systemic
KW  - chemically induced
KW  - Male
KW  - Middle Aged
KW  - Pharmacovigilance
KW  - Receptors, Tumor Necrosis Factor
KW  - therapeutic use
KW  - Risk Factors
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1093/rheumatology/keu214
ER  -